首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products
【24h】

A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products

机译:葡萄糖降解产物含量低的腹膜透析液的临床和生化特征研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Although peritoneal dialysis (PD) is a widely accepted form of renal replacement therapy, concerns remain regarding the bioincompatible nature of standard PD fluid (PDF). Short-term studies of new biocompatible PDFs low in glucose degradation products (GDPs) reveal divergent results with respect to peritoneal integrity. Methods: We studied 125 patients on maintenance PD who were assigned, by simple randomization, to receive either conventional or low-GDP PDF at PD initiation. Parameters of dialysis adequacy and peritoneal transport of small solutes were determined at initiation and after a period of maintenance PD at the time when serum and overnight effluent dialysate were simultaneously collected and assayed for various cytokines, chemokines, adipokines, and cardiac biomarkers. All patients were further followed prospectively for an average of 15 months from the day of serum and effluent collection to determine patient survival and cardiovascular events. Results: Patients treated with conventional or low-GDP PDF were matched for sex, age, duration of dialysis, dialysis adequacy, and incidence of cardiovascular disease or diabetes. After an average of 2.3 years of PD treatment, the weekly total and peritoneal creatinine clearance, and the total and peritoneal Kt/V were comparable in the groups. However, urine output was higher in patients using low-GDP PDF despite there having been no difference between the groups at PD initiation. Patients using low-GDP PDF also experienced a slower rate of decline of residual glomerular filtration and urine output than did patients on conventional PDF. Compared with serum concentrations, effluent concentrations of tumor necrosis factor α, hepatocyte growth factor, macrophage migration inhibitory factor, interleukins 8 and 6, C-reactive protein, and leptin were found to be higher in both groups of patients after long-term PD, suggesting that the peritoneal cavity was the major source of those mediators. Compared with patients on low-GDP PDF, patients on conventional fluid showed elevated leptin and reduced adiponectin levels in serum and effluent. The effluent concentration of interleukin 8 was significantly lower in patients using low-GDP PDF. The survival rate and incidence of cardiovascular complications did not differ between these groups after maintenance PD for an average of 3.6 years. Conclusions: It appears that low-GDP PDF results in an improvement of local peritoneal homeostasis through a reduction of chronic inflammatory status in the peritoneum.
机译:目的:尽管腹膜透析(PD)是肾脏替代疗法的一种广泛接受的形式,但人们仍对标准PD液(PDF)的生物相容性感到担忧。对低葡萄糖降解产物(GDPs)的新型生物相容性PDF的短期研究显示,其腹膜完整性存在分歧。方法:我们研究了125位维持性PD患者,这些患者通过简单随机分配被分配为在PD开始时接受常规或低GDP PDF。透析开始时和维持一段时间后,在同时采集血清和过夜流出的透析液并分析各种细胞因子,趋化因子,脂肪因子和心脏生物标志物时,确定透析充分性和小溶质的腹膜转运参数。从收集血清和废水之日起,对所有患者进行前瞻性平均随访15个月,以确定患者的存活率和心血管事件。结果:接受常规或低GDP PDF治疗的患者在性别,年龄,透析时间,透析充分性以及心血管疾病或糖尿病的发生率方面均相匹配。经过平均2.3年的PD治疗,各组每周的总和腹膜肌酐清除率以及总和腹膜Kt / V相当。然而,尽管PD开始时两组之间没有差异,但使用低GDP PDF的患者的尿量较高。与传统PDF相比,使用低GDP的PDF的患者肾小球滤过残留和尿量下降的速度也较慢。与血清浓度相比,长期PD后两组患者的肿瘤坏死因子α,肝细胞生长因子,巨噬细胞迁移抑制因子,白介素8和6,C反应蛋白和瘦素的流出物浓度均较高,提示腹膜腔是这些介质的主要来源。与低GDP PDF的患者相比,常规输液的患者血清和污水中的瘦素水平升高,脂联素水平降低。使用低GDP PDF的患者白细胞介素8的流出浓度显着降低。维持PD后平均3。6年,两组之间的生存率和心血管并发症的发生率无差异。结论:低GDP PDF似乎通过减少腹膜中的慢性炎症状态而改善了局部腹膜稳态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号